An Unexpected Lower Urinary Tract Symptom of Multiple Sclerosis: Valsalva Induced Urge Incontinence
Murat Akgul, MD, CenkYazıici, MD, NildaTurgut, MD, Arzu Malak and Mehmet Fatih Sahin, MD
Article Type: CASE REPORT | First Published: February 28, 2019
A 46-years-old male with the history of multiple sclerosis applied to urology outpatient clinic with frequency, urgency, incontinence, and nocturia. Urodynamic evaluation presented Valsalva-induced urge incontinence, which was an unusual finding for an MS patient. Here we present an MS patient with the urodynamic finding of Valsalva-induced urge incontinence. Multiple sclerosis (MS) is a chronic progressive demyelinating disease of the central nervous system, mostly affecting the people between ...
Management of Non-Classic Congenital Adrenal Hyperplasia in Pregnant Woman - Non-Referral Center Experience- Case Report
Zoran Gluvic, Milena Lackovic, Vladimir Samardzic, Bojan Mitrovic, Violeta Mladenovic, Milan Obradovic, Danimir Jevremovic and Esma R Isenovic
Article Type: Case Report | First Published: February 22, 2019
Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disorder with mutations in genes involved in cortisol and aldosterone production. Based on overall 21-OHase activity, CAH is divided into classic (C-CAH) and non-classic (NC-CAH). Females who suffered from NC-CAH have had increased infertility rates and higher miscarriage susceptibility. The treatment of CAH in pregnancy is still debatable. We present 22 years old pregnant female (seventh week of gestation), who is currently unde...
High Focused Ultrasound in a Case of Previously Untreated Breast Cancer
Hans-Christian Kolberg, MD, PhD and Cornelia Kolberg-Liedtke, MD, PhD
Article Type: Case Report | First Published: February 20, 2019
High focused ultrasound is a non-invasive treatment used for destroying benign and potentially also malignant tumors. Recent data have suggested that the generation of large volumes of tumor debris by high focused ultrasound may initiate an adaptive antitumor immune response by the release of tumor antigens and damage associated molecular patterns. The patient, a 48-year-old woman who was diagnosed with hormone receptor positive HER2 negative breast cancer 17 months before presentation had repea...
Soluble ST2 - A Potential Biomarker of Rheumatic Heart Disease
Ramona Januska, MD, Alexander von Meyer, MD, Martin Fleck, MD and Andreas Luchner, MD
Article Type: Case Report | First Published: February 18, 2019
Soluble ST2 might be a sensitive marker of rheumatic (peri-)carditis before and during antirheumatic treatment. We describe a case of rheumatic heart disease with pericarditis and mild left ventricular dysfunction which was successfully treated by immunosuppression. An interesting pattern of activation of the cardiac marker ST2 was observed at detection and during treatment. It suggests ST2 as biomarker for diagnosis and monitoring of disease activity in rheumatic heart disease. Rheumatic disord...